Davidson A, Skowno J Neuromonitoring in paediatric anaesthesia. Curr Opin Anaesthesiol. 2019 Jun;32(3):370-376. doi: 10.1097/ACO.0000000000000732.
Eisele JH, Eger EI 2nd, Muallem M Narcotic properties of carbon dioxide in the dog. Anesthesiology. 1967 Sep-Oct;28(5):856-65. doi: 10.1097/00000542-196709000-00019. No abstract available.
Fukuda T, Hisano S, Toyooka H Moderate hypercapnia-induced anesthetic effects and endogenous opioids. Neurosci Lett. 2006 Jul 31;403(1-2):20-3. doi: 10.1016/j.neulet.2006.04.026. Epub 2006 May 15.
Gronroos M, Pertovaara A A selective suppression of human pain sensitivity by carbon dioxide: central mechanisms implicated. Eur J Appl Physiol Occup Physiol. 1994;68(1):74-9. doi: 10.1007/BF00599245.
Leake CD, Waters RM Leake CD, Waters RM (1928) The anaesthetic properties of carbon dioxide. J Pharmacol Exp Ther 33:280-281. In.
Louvet N, Rigouzzo A, Sabourdin N, Constant I Bispectral index under propofol anesthesia in children: a comparative randomized study between TIVA and TCI. Paediatr Anaesth. 2016 Sep;26(9):899-908. doi: 10.1111/pan.12957.
McFarlan CS, Anderson BJ, Short TG The use of propofol infusions in paediatric anaesthesia: a practical guide. Paediatr Anaesth. 1999;9(3):209-16.
Narayanan H, Raistrick C, Tom Pierce JM, Shelton C Carbon footprint of inhalational and total intravenous anaesthesia for paediatric anaesthesia: a modelling study. Br J Anaesth. 2022 Aug;129(2):231-243. doi: 10.1016/j.bja.2022.04.022. Epub 2022 Jun 18.
Saghaei M, Matin G, Golparvar M Effects of intra-operative end-tidal carbon dioxide levels on the rates of post-operative complications in adults undergoing general anesthesia for percutaneous nephrolithotomy: A clinical trial. Adv Biomed Res. 2014 Feb 28;3:84. doi: 10.4103/2277-9175.127997. eCollection 2014.
Wang F, Zhang J, Yu J, Tian M, Cui X, Wu A Variation of bispectral index in children aged 1-12 years under propofol anesthesia: an observational study. BMC Anesthesiol. 2019 Aug 7;19(1):145. doi: 10.1186/s12871-019-0815-6.
Whitesell R, Asiddao C, Gollman D, Jablonski J Relationship between arterial and peak expired carbon dioxide pressure during anesthesia and factors influencing the difference. Anesth Analg. 1981 Jul;60(7):508-12.
WOODBURY DM, KARLER R The role of carbon dioxide in the nervous system. Anesthesiology. 1960 Nov-Dec;21:686-703. doi: 10.1097/00000542-196011000-00012. No abstract available.
Wu Z, Yu J, Zhang T, Tan H, Li H, Xie L, Lin W, Shen D, Cao L Effects of Etco2 on the Minimum Alveolar Concentration of Sevoflurane that Blunts the Adrenergic Response to Surgical Incision: A Prospective, Randomized, Double-Blinded Trial. Anesth Analg. 2022 Jul 1;135(1):62-70. doi: 10.1213/ANE.0000000000005784. Epub 2022 Jun 16.
Yamaguchi J, Kinoshita K, Hosokawa T, Ihara S "The eyes are the windows of the soul": Portable automated pupillometry to monitor autonomic nervous activity in CO2 narcosis: A case report. Medicine (Baltimore). 2023 May 12;102(19):e33768. doi: 10.1097/MD.0000000000033768.
Effects of End Tidal Carbon Dioxide Concentration on Depth of Anesthesia in Children Undergoing Total Intravenous Anesthesia
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.